II.8 Significance of benign uterine pathology on tamoxifen
- 31 August 1998
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 34, S26-S27
- https://doi.org/10.1016/s0959-8049(98)00097-5
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomasOncogene, 1997
- Induction of Mucous Metaplasia in Chick Embryonic Skin by Retinol‐Pretreated Embryonic Chick or Quail Dermal Fibroblasts through Cell‐Cell Interaction: Correlation of a Transient Increase in Retinoic Acid Receptor β mRNA in Retinol‐Treated Dermal Fibroblasts with Their Competence to Induce Epidermal Mucous MetaplasiaDevelopment, Growth & Differentiation, 1994
- Pathology of endometrium treated with tamoxifen.Journal of Clinical Pathology, 1994
- Intestinal metaplasia of the stomach. A status reportCancer, 1994
- Endometrial lesions in patients undergoing tamoxifen therapyInternational Journal of Gynecology & Obstetrics, 1991
- Hysteroscopic follow-up during Tamoxifen treatmentEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1990
- Endometrial Polyps in Postmenopausal Patients Receiving TamoxifenInternational Journal of Gynecological Pathology, 1989
- Barrett's EsophagusNew England Journal of Medicine, 1986